MindMate: A Study of a Reminder System for People With Dementia

NCT ID: NCT02908997

Last Updated: 2018-11-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

3 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-01-17

Study Completion Date

2018-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A study to investigate the effectiveness of a reminder tool application at increasing performance on memory tasks in people with mild dementia

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Background

Memory difficulties are a core feature of dementia. These include difficulties remembering to do something at a specific time and place in the future (Prospective Memory). Although a range of electronic prospective memory aids currently exist (e.g. "Neuropage"), the evidence supporting their use among the dementia population remains limited. "Mindmate" is a recently developed mobile application that aims to support individuals with a diagnosis of dementia, improving self-management skills and quality of life.

Aims

This study will explore the effectiveness of "MindMate" reminder alerts delivered to a smart phone or tablet computer as a memory aid for people with a diagnosis of Mild Dementia.

Method

Three participants with a diagnosis of dementia, who are considered to be in the early stages and who report everyday prospective memory difficulties, will be recruited from Older People Community Mental Health teams within Greater Glasgow and Clyde. The participants will own a smart phone or tablet and will be living with a partner or family member who will also participate in the study. During the initial baseline phase, the partner or family member will monitor the number of pre defined tasks the participant remembered and forgot. The partner or family member will record this information on a weekly monitoring form and this phase will last between five to seven weeks. This will be followed by a five-week intervention phase where "MindMate" reminder alerts will be sent to the participant's phone or tablet. Again, tasks that require remembering will be identified prior to the intervention phase, and family members or carers will monitor their success on a form. Results will be analysed using visual inspection and Tau-U analysis.

Applications

This study will provide information on the effectiveness of a form of assistive technology at supporting people with a dementia, which could improve quality of life of those with a diagnosis.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dementia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

5 week baseline

5 week baseline data collection followed by 6 week MindMate intervention

Group Type EXPERIMENTAL

MindMate

Intervention Type OTHER

A dementia-specific mobile reminding application

6 week baseline

6 week baseline data collection followed by 6 week MindMate intervention

Group Type EXPERIMENTAL

MindMate

Intervention Type OTHER

A dementia-specific mobile reminding application

7 week baseline

7 week baseline data collection followed by 6 week MindMate intervention

Group Type EXPERIMENTAL

MindMate

Intervention Type OTHER

A dementia-specific mobile reminding application

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

MindMate

A dementia-specific mobile reminding application

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* has a diagnosis of Mild Dementia, according to International Classification of Diseases (ICD) 10 Criteria
* has received the diagnosis from a psychiatrist
* owns a smart phone or tablet
* has a family member/partner/carer who is willing to monitor memory aid use
* has capacity to consent to being involved in the research
* is reporting memory difficulties that are affecting them in daily life

Exclusion Criteria

* visual or auditory difficulties which cannot be corrected through the use of appropriate aids
* has a pre-existing neurological or severe psychiatric problem (e.g. bipolar disorder, psychosis)
* has a diagnosis of dementia that is considered to be in the moderate to severe stages
* those whose first language is not English
* those with a diagnosed or suspected developmental learning disability
* those who are currently using online or electronic memory aids
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Glasgow

OTHER

Sponsor Role collaborator

NHS Greater Glasgow and Clyde

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jonathan Evans, BSc DClinPsy PhD

Role: PRINCIPAL_INVESTIGATOR

University of Glasgow

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

NHS Greater Glasgow and Clyde

Glasgow, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

GN16NE538

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Memory and Mental Health in Aging
NCT02988908 COMPLETED PHASE4
The Use of Memantine for Prevention of Alzheimer's Disease
NCT05063851 ACTIVE_NOT_RECRUITING PHASE2
Screening for Memory Studies
NCT01123018 ACTIVE_NOT_RECRUITING